Menu

Cancer Stem Cells: Getting to the Root of Cancer

The Scientist is bringing together a panel of experts to share their results, as well as the lessons they’ve learned from studying the root cause of cancer.

Aug 6, 2017
The Scientist Creative Services Team

Cancer Stem Cells: Getting to the Root of Cancer from thescientistllc on Vimeo.

The stem cell theory of cancer implies that anticancer therapies must target and destroy all resident cancer stem cells, in order to produce a durable response. Therapies that target cancer stem cells are currently being tested to confirm their safety and efficacy, but research into the weaknesses of cancer stem cells continues. To explore the knowns and unknowns in the field of cancer stem cell research, The Scientist is bringing together a panel of experts to share their results, as well as the lessons they’ve learned from studying the root cause of cancer. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics related to their research.

Topics to be covered:

  • How stem cells become cancer stem cells
  • Methods for constraining cancer stem cell proliferation

Meet the Speakers:

Irving Weissman, MD
Director, Institute for Stem Cell Biology and Regenerative Medicine
Stanford University School of Medicine

 

 

Alka Mansukhani, PhD
Associate Professor, Department of Microbiology
New York University School Of Medicine

 

 

 

 

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.